rs7298287
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001414.4(EIF2B1):c.370-20A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0909 in 1,603,222 control chromosomes in the GnomAD database, including 13,539 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.19 ( 5082 hom., cov: 32)
Exomes 𝑓: 0.081 ( 8457 hom. )
Consequence
EIF2B1
NM_001414.4 intron
NM_001414.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.54
Genes affected
EIF2B1 (HGNC:3257): (eukaryotic translation initiation factor 2B subunit alpha) This gene encodes one of five subunits of eukaryotic translation initiation factor 2B (EIF2B), a GTP exchange factor for eukaryotic initiation factor 2 and an essential regulator for protein synthesis. Mutations in this gene and the genes encoding other EIF2B subunits have been associated with leukoencephalopathy with vanishing white matter. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-123627176-T-C is Benign according to our data. Variant chr12-123627176-T-C is described in ClinVar as [Benign]. Clinvar id is 93731.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.467 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF2B1 | ENST00000424014.7 | c.370-20A>G | intron_variant | Intron 4 of 8 | 1 | NM_001414.4 | ENSP00000416250.2 | |||
EIF2B1 | ENST00000537073.1 | c.370-20A>G | intron_variant | Intron 4 of 4 | 2 | ENSP00000444183.1 | ||||
EIF2B1 | ENST00000539951.5 | c.331-20A>G | intron_variant | Intron 3 of 6 | 5 | ENSP00000438060.1 | ||||
EIF2B1 | ENST00000534960.5 | c.415-2314A>G | intron_variant | Intron 4 of 5 | 5 | ENSP00000443172.1 |
Frequencies
GnomAD3 genomes AF: 0.186 AC: 28208AN: 151924Hom.: 5036 Cov.: 32
GnomAD3 genomes
AF:
AC:
28208
AN:
151924
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.108 AC: 27245AN: 251366Hom.: 2912 AF XY: 0.103 AC XY: 14026AN XY: 135866
GnomAD3 exomes
AF:
AC:
27245
AN:
251366
Hom.:
AF XY:
AC XY:
14026
AN XY:
135866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0809 AC: 117442AN: 1451180Hom.: 8457 Cov.: 28 AF XY: 0.0822 AC XY: 59389AN XY: 722584
GnomAD4 exome
AF:
AC:
117442
AN:
1451180
Hom.:
Cov.:
28
AF XY:
AC XY:
59389
AN XY:
722584
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.186 AC: 28316AN: 152042Hom.: 5082 Cov.: 32 AF XY: 0.184 AC XY: 13654AN XY: 74328
GnomAD4 genome
AF:
AC:
28316
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
13654
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
602
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Aug 09, 2012
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at